Long-term infuence of bone marrow-derived mesenchymal stem cells on liver ischemia-reperfusion injury in a rat model

Maciej Nowacki, Łukasz Nazarewski, Marta Pokrywczyńska, Tomasz Kloskowski, Dominik Tyloch, Katarzyna Pietkun, Arkadiusz Jundziłł, Marta Rasmus, Karolina Warda, Maciej Gagat, Alina Grzanka, Magdalena Bodnar, Andrzej Marszałek, Marek Krawczyk, Samy L Habib, Tomasz Drewa

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background: The aim of this study was to evaluate the long-term usefulness of intraportal injection of the bone marrow-derived mesenchymal stem cells (BM-MSCs) in limitation of experimentally induced ischemia-reperfusion injury (IRI) in a rat model. Material/Methods: Twenty Wistar rats were divided into 3 groups: donor group (n=5), study group (n=10), and control group (n=5). IRI was performed using a modifed hanging-weight system after left portal triad occlusion in study group animals. Isolated autologous BM-MSCs were labeled with fuorochrome PKH-26 then intraportally injected into the rats in the study group. Control group animals were intraportally injected with 1 ml of PBS. Follow-up was 3 months, after which animals were sacrifced for histopathological examination. Migration of BM-MSCs into diferent organs was examined. Results: H&E staining of liver tissue sections from “time zero” biopsies did not show many irregularities in structural or histological construction compared to liver sections from the control group. However, a small amount of cen-trilobular hepatocyte necrosis and coagulative necrosis with neutrophil infltration areas was observed in liver sections of the study group. The migration assay of BM-MSCs labeled with PKH-26 showed the highest positive BM-MSCs staining (6%) in the spleen, while few positively stained cells were found (2%) in liver sections. No BM-MSCs were detected in brain, kidney, or lung tissues. Conclusions: These results suggest that intraportal bone marrow-de rived mesenchymal stem cell injection is safe and cells do not migrate chaotically to other organs after targeted implementation.

Original languageEnglish (US)
Pages (from-to)132-140
Number of pages9
JournalAnnals of Transplantation
Volume20
DOIs
StatePublished - Mar 10 2015

Fingerprint

Reperfusion Injury
Mesenchymal Stromal Cells
Bone Marrow
Liver
Control Groups
Necrosis
Staining and Labeling
Injections
Wistar Rats
Hepatocytes
Neutrophils
Spleen
Kidney
Biopsy
Weights and Measures
Lung
Brain

Keywords

  • Mesenchymal stromal cells
  • Reperfusion injury
  • Tissue engineering

ASJC Scopus subject areas

  • Transplantation

Cite this

Nowacki, M., Nazarewski, Ł., Pokrywczyńska, M., Kloskowski, T., Tyloch, D., Pietkun, K., ... Drewa, T. (2015). Long-term infuence of bone marrow-derived mesenchymal stem cells on liver ischemia-reperfusion injury in a rat model. Annals of Transplantation, 20, 132-140. https://doi.org/10.12659/AOT.892364

Long-term infuence of bone marrow-derived mesenchymal stem cells on liver ischemia-reperfusion injury in a rat model. / Nowacki, Maciej; Nazarewski, Łukasz; Pokrywczyńska, Marta; Kloskowski, Tomasz; Tyloch, Dominik; Pietkun, Katarzyna; Jundziłł, Arkadiusz; Rasmus, Marta; Warda, Karolina; Gagat, Maciej; Grzanka, Alina; Bodnar, Magdalena; Marszałek, Andrzej; Krawczyk, Marek; Habib, Samy L; Drewa, Tomasz.

In: Annals of Transplantation, Vol. 20, 10.03.2015, p. 132-140.

Research output: Contribution to journalArticle

Nowacki, M, Nazarewski, Ł, Pokrywczyńska, M, Kloskowski, T, Tyloch, D, Pietkun, K, Jundziłł, A, Rasmus, M, Warda, K, Gagat, M, Grzanka, A, Bodnar, M, Marszałek, A, Krawczyk, M, Habib, SL & Drewa, T 2015, 'Long-term infuence of bone marrow-derived mesenchymal stem cells on liver ischemia-reperfusion injury in a rat model', Annals of Transplantation, vol. 20, pp. 132-140. https://doi.org/10.12659/AOT.892364
Nowacki, Maciej ; Nazarewski, Łukasz ; Pokrywczyńska, Marta ; Kloskowski, Tomasz ; Tyloch, Dominik ; Pietkun, Katarzyna ; Jundziłł, Arkadiusz ; Rasmus, Marta ; Warda, Karolina ; Gagat, Maciej ; Grzanka, Alina ; Bodnar, Magdalena ; Marszałek, Andrzej ; Krawczyk, Marek ; Habib, Samy L ; Drewa, Tomasz. / Long-term infuence of bone marrow-derived mesenchymal stem cells on liver ischemia-reperfusion injury in a rat model. In: Annals of Transplantation. 2015 ; Vol. 20. pp. 132-140.
@article{69bbf544738b4ff6bcbbed91bebe5a75,
title = "Long-term infuence of bone marrow-derived mesenchymal stem cells on liver ischemia-reperfusion injury in a rat model",
abstract = "Background: The aim of this study was to evaluate the long-term usefulness of intraportal injection of the bone marrow-derived mesenchymal stem cells (BM-MSCs) in limitation of experimentally induced ischemia-reperfusion injury (IRI) in a rat model. Material/Methods: Twenty Wistar rats were divided into 3 groups: donor group (n=5), study group (n=10), and control group (n=5). IRI was performed using a modifed hanging-weight system after left portal triad occlusion in study group animals. Isolated autologous BM-MSCs were labeled with fuorochrome PKH-26 then intraportally injected into the rats in the study group. Control group animals were intraportally injected with 1 ml of PBS. Follow-up was 3 months, after which animals were sacrifced for histopathological examination. Migration of BM-MSCs into diferent organs was examined. Results: H&E staining of liver tissue sections from “time zero” biopsies did not show many irregularities in structural or histological construction compared to liver sections from the control group. However, a small amount of cen-trilobular hepatocyte necrosis and coagulative necrosis with neutrophil infltration areas was observed in liver sections of the study group. The migration assay of BM-MSCs labeled with PKH-26 showed the highest positive BM-MSCs staining (6{\%}) in the spleen, while few positively stained cells were found (2{\%}) in liver sections. No BM-MSCs were detected in brain, kidney, or lung tissues. Conclusions: These results suggest that intraportal bone marrow-de rived mesenchymal stem cell injection is safe and cells do not migrate chaotically to other organs after targeted implementation.",
keywords = "Mesenchymal stromal cells, Reperfusion injury, Tissue engineering",
author = "Maciej Nowacki and Łukasz Nazarewski and Marta Pokrywczyńska and Tomasz Kloskowski and Dominik Tyloch and Katarzyna Pietkun and Arkadiusz Jundziłł and Marta Rasmus and Karolina Warda and Maciej Gagat and Alina Grzanka and Magdalena Bodnar and Andrzej Marszałek and Marek Krawczyk and Habib, {Samy L} and Tomasz Drewa",
year = "2015",
month = "3",
day = "10",
doi = "10.12659/AOT.892364",
language = "English (US)",
volume = "20",
pages = "132--140",
journal = "Annals of Transplantation",
issn = "1425-9524",
publisher = "International Scientific Information, Inc.",

}

TY - JOUR

T1 - Long-term infuence of bone marrow-derived mesenchymal stem cells on liver ischemia-reperfusion injury in a rat model

AU - Nowacki, Maciej

AU - Nazarewski, Łukasz

AU - Pokrywczyńska, Marta

AU - Kloskowski, Tomasz

AU - Tyloch, Dominik

AU - Pietkun, Katarzyna

AU - Jundziłł, Arkadiusz

AU - Rasmus, Marta

AU - Warda, Karolina

AU - Gagat, Maciej

AU - Grzanka, Alina

AU - Bodnar, Magdalena

AU - Marszałek, Andrzej

AU - Krawczyk, Marek

AU - Habib, Samy L

AU - Drewa, Tomasz

PY - 2015/3/10

Y1 - 2015/3/10

N2 - Background: The aim of this study was to evaluate the long-term usefulness of intraportal injection of the bone marrow-derived mesenchymal stem cells (BM-MSCs) in limitation of experimentally induced ischemia-reperfusion injury (IRI) in a rat model. Material/Methods: Twenty Wistar rats were divided into 3 groups: donor group (n=5), study group (n=10), and control group (n=5). IRI was performed using a modifed hanging-weight system after left portal triad occlusion in study group animals. Isolated autologous BM-MSCs were labeled with fuorochrome PKH-26 then intraportally injected into the rats in the study group. Control group animals were intraportally injected with 1 ml of PBS. Follow-up was 3 months, after which animals were sacrifced for histopathological examination. Migration of BM-MSCs into diferent organs was examined. Results: H&E staining of liver tissue sections from “time zero” biopsies did not show many irregularities in structural or histological construction compared to liver sections from the control group. However, a small amount of cen-trilobular hepatocyte necrosis and coagulative necrosis with neutrophil infltration areas was observed in liver sections of the study group. The migration assay of BM-MSCs labeled with PKH-26 showed the highest positive BM-MSCs staining (6%) in the spleen, while few positively stained cells were found (2%) in liver sections. No BM-MSCs were detected in brain, kidney, or lung tissues. Conclusions: These results suggest that intraportal bone marrow-de rived mesenchymal stem cell injection is safe and cells do not migrate chaotically to other organs after targeted implementation.

AB - Background: The aim of this study was to evaluate the long-term usefulness of intraportal injection of the bone marrow-derived mesenchymal stem cells (BM-MSCs) in limitation of experimentally induced ischemia-reperfusion injury (IRI) in a rat model. Material/Methods: Twenty Wistar rats were divided into 3 groups: donor group (n=5), study group (n=10), and control group (n=5). IRI was performed using a modifed hanging-weight system after left portal triad occlusion in study group animals. Isolated autologous BM-MSCs were labeled with fuorochrome PKH-26 then intraportally injected into the rats in the study group. Control group animals were intraportally injected with 1 ml of PBS. Follow-up was 3 months, after which animals were sacrifced for histopathological examination. Migration of BM-MSCs into diferent organs was examined. Results: H&E staining of liver tissue sections from “time zero” biopsies did not show many irregularities in structural or histological construction compared to liver sections from the control group. However, a small amount of cen-trilobular hepatocyte necrosis and coagulative necrosis with neutrophil infltration areas was observed in liver sections of the study group. The migration assay of BM-MSCs labeled with PKH-26 showed the highest positive BM-MSCs staining (6%) in the spleen, while few positively stained cells were found (2%) in liver sections. No BM-MSCs were detected in brain, kidney, or lung tissues. Conclusions: These results suggest that intraportal bone marrow-de rived mesenchymal stem cell injection is safe and cells do not migrate chaotically to other organs after targeted implementation.

KW - Mesenchymal stromal cells

KW - Reperfusion injury

KW - Tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=84924555354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924555354&partnerID=8YFLogxK

U2 - 10.12659/AOT.892364

DO - 10.12659/AOT.892364

M3 - Article

VL - 20

SP - 132

EP - 140

JO - Annals of Transplantation

JF - Annals of Transplantation

SN - 1425-9524

ER -